Sagimet Biosciences (SGMT) Stock Insights

SGMT price $10.53 +0.10 +1.01%

Ticker
SGMT
Price
$10.53
Change
+0.10 +1.01%
Market cap ?
$342.92M
Beta ?
3.49
Sector
Healthcare
Industry
Biotechnology

Fair value

SGMT fair value $16.32. Price $10.53. Price is 35% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 168.06K. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 32.58M. Net debt -34.94M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare SGMT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.25—166.67K
2026-08-11-0.26-0.25——
2026-05-12-0.33-0.39——
2026-03-11-0.29-0.43—1.11M
2025-11-13-0.40-0.41——
2025-08-13-0.32-0.52——
2025-05-08-0.56-0.79——
2025-03-12-0.50-0.65——
2024-11-14-0.45-0.47——
2024-08-14-0.25-0.34——
2024-05-15-0.23-0.41——
2024-03-25-0.78-0.58——
2023-11-13-0.35-1.022.00M—
2023-07-14-35.80-0.50——
2023-03-31-0.30———
2022-12-31-0.32———
2022-09-30-0.34———
2022-06-30-0.32———
2022-03-31-0.39———
2021-03-31-0.25———
2020-03-31-0.18———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-14Kemble GeorgeBuy24.37K$6.36154.99K
2026-08-14Kemble GeorgeBuy326.62K$6.362.08M
2026-08-14Kemble GeorgeSell350.99K$10.233.59M
2026-08-14Kemble GeorgeSell326.62K$6.362.08M
2026-08-14Kemble GeorgeSell24.37K$6.36154.99K
2026-08-11Kemble GeorgeSell9.75K$6.3662.02K
2026-08-11Kemble GeorgeBuy10.46K$6.3666.49K
2026-08-11Kemble GeorgeBuy9.75K$6.3662.02K
2026-08-11Kemble GeorgeSell20.21K$9.95201.15K
2026-08-11Kemble GeorgeSell10.46K$6.3666.49K
2026-07-20Happel DavidSell64.05K$7.76497.07K
2026-07-20Rozek ElizabethSell10.54K$7.7681.83K
2026-07-20Kemble GeorgeSell18.84K$7.46140.53K
2026-06-12SEIDENBERG BETH CBuy39.57K$6.48256.39K
2026-06-12Hoelscher Paul W.Buy39.57K$6.48256.39K
2026-06-12Jarrett JenniferBuy39.57K$6.48256.39K
2026-06-12GRAMMER ELIZABETH ABuy39.57K$6.48256.39K
2026-06-12Kemble GeorgeBuy39.57K$6.48256.39K
2026-06-12Phillips Anne M.Buy39.57K$6.48256.39K
2026-05-28Chauche ThierryBuy50.00K$7.27363.50K
2026-05-28Grauer AndreasBuy35.00K$7.27254.45K
2026-05-28Rozek ElizabethBuy100.00K$7.27727.00K
2026-05-28Happel DavidBuy300.00K$7.272.18M
2026-04-20Grauer AndreasBuy264.76K$6.441.71M
2026-04-20Grauer AndreasOther0——
2026-02-19Rozek ElizabethBuy44.00K——
2026-02-19Rozek ElizabethBuy88.00K$5.38473.44K
2026-02-19Martins Eduardo BrunoBuy44.00K——
2026-02-19Martins Eduardo BrunoBuy88.00K$5.38473.44K
2026-02-19Happel DavidBuy128.00K——
2026-02-19Happel DavidBuy256.00K$5.381.38M
2026-02-19Chauche ThierryBuy88.00K$5.38473.44K
2026-02-19Chauche ThierryBuy44.00K——
2026-02-10Happel DavidSell12.10K$5.3664.86K
2026-02-10Chauche ThierrySell1.31K$5.367.03K
2026-02-10Martins Eduardo BrunoSell3.64K$5.3619.51K
2026-02-10Rozek ElizabethSell2.62K$5.3614.05K
2025-11-20Kemble GeorgeSell37.69K$7.69289.98K
2025-11-04Rozek ElizabethBuy9.86K——
2025-11-04Rozek ElizabethBuy13.37K$7.61101.72K
2025-07-21Happel DavidSell65.48K$9.13598.12K
2025-07-21Martins Eduardo BrunoSell8.28K$9.1375.61K
2025-07-21Rozek ElizabethSell10.78K$9.1398.47K
2025-06-09Walbert Timothy PBuy32.25K$5.33171.89K
2025-06-09SEIDENBERG BETH CBuy32.25K$5.33171.89K
2025-06-09Phillips Anne M.Buy27.27K$5.33145.34K
2025-06-09Kemble GeorgeBuy32.25K$5.33171.89K
2025-06-09Jarrett JenniferBuy27.27K$5.33145.34K
2025-06-09Hoelscher Paul W.Buy32.25K$5.33171.89K
2025-06-09GRAMMER ELIZABETH ABuy32.25K$5.33171.89K
2025-06-06SEIDENBERG BETH CBuy28.52K$5.56158.58K
2025-02-06Martins Eduardo BrunoBuy138.00K$4.71649.98K
2025-02-06Martins Eduardo BrunoBuy34.00K——
2025-02-06Happel DavidBuy116.00K——
2025-02-06Happel DavidBuy472.00K$4.712.22M
2025-02-06Rozek ElizabethBuy34.00K——
2025-02-06Rozek ElizabethBuy138.00K$4.71649.98K
2025-02-06Chauche ThierryBuy69.00K$4.71324.99K
2025-02-06Chauche ThierryBuy17.00K——
2024-08-01Jarrett JenniferBuy113.89K$3.48396.35K
2024-08-01Phillips Anne M.Buy113.89K$3.48396.35K
2024-08-01Jarrett JenniferOther0——
2024-08-01Phillips Anne M.Other0——
2024-07-23Kemble GeorgeSell23.62K$3.1774.83K
2024-07-19Martins Eduardo BrunoSell8.36K$3.1025.91K
2024-07-19Rozek ElizabethSell10.91K$3.1033.83K
2024-07-19Kemble GeorgeSell14.06K$3.1043.60K
2024-06-05Walbert Timothy PBuy9.28K$4.6443.05K
2024-06-05SEIDENBERG BETH CBuy51.46K$4.64238.77K
2024-06-05Parsey MerdadBuy51.46K$4.64238.77K
2024-06-05Hoelscher Paul W.Buy9.28K$4.6443.05K
2024-06-05GRAMMER ELIZABETH ABuy51.46K$4.64238.77K
2024-05-06Chauche ThierryBuy587.18K$4.282.51M
2024-05-06Chauche ThierryOther0——
2024-04-01Walbert Timothy PBuy73.01K$5.23381.86K
2024-04-01Hoelscher Paul W.Buy73.01K$5.23381.86K
2024-04-01Walbert Timothy PSell0——
2024-04-01Hoelscher Paul W.Other0——
2024-03-26Happel DavidBuy12.10K$5.2763.73K
2024-01-29SANDELL SCOTT DSell850.00K——
2024-01-29SANDELL SCOTT DBuy260.95K——
2024-01-29SANDELL SCOTT DBuy7.00K——
2024-01-29SANDELL SCOTT DSell260.95K——
2024-01-29NEW ENTERPRISE ASSOCIATES 13 LPSell850.00K——
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPBuy30.00K$16.00480.00K
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPBuy13.40K$0.7910.65K
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPSell662$16.0010.59K
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPBuy3.77M——
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPBuy37.68K——
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPSell11.36M——
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPSell37.68K——
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPSell23.04M——
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPSell14.66M——
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPSell11.36M——
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPSell13.40K$0.7910.65K
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPSell237.89M——
2023-07-18NEW ENTERPRISE ASSOCIATES 13 LPSell1.30M——
2023-07-18GRAMMER ELIZABETH ABuy49.53K$8.74432.92K
2023-07-18GRAMMER ELIZABETH ASell49.53K$8.74432.92K
2023-07-13NEW ENTERPRISE ASSOCIATES 13 LPSell0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 130, holders +37 vs prior quarter. Ownership 96.38%.

HolderSharesChangeChange %Value
BLACKROCK, INC.6.58M5.78M+722.03%50.83M
BALYASNY ASSET MANAGEMENT L.P.3.63M3.63MNew28.03M
WOODLINE PARTNERS LP3.00M2.00M+199.78%23.20M
SILVERARC CAPITAL MANAGEMENT, LLC2.93M2.93MNew22.63M
VANGUARD CAPITAL MANAGEMENT LLC2.57M1.47M+133.53%19.84M
CALIGAN PARTNERS LP2.50M2.50MNew19.32M
BVF INC/IL2.50M2.50MNew19.32M
AFFINITY ASSET ADVISORS, LLC2.50M1.63M+187.77%19.31M
FEDERATED HERMES, INC.2.09M2.09M+267085.02%16.13M
GREAT POINT PARTNERS LLC2.03M2.03MNew15.69M
STATE STREET CORP2.00M1.87M+1449.13%15.42M
SATURN V CAPITAL MANAGEMENT LP1.48M1.48MNew11.44M
GEODE CAPITAL MANAGEMENT, LLC1.44M1.13M+366.53%11.17M
BLUE OWL CAPITAL HOLDINGS LP1.26M926.67K+277.55%9.74M
BAKER BROS. ADVISORS LP953.00K00.00%7.37M
MILLENNIUM MANAGEMENT LLC937.02K74.72K+8.67%7.24M
ABERDEEN GROUP PLC847.70K847.70KNew6.55M
GOLDMAN SACHS GROUP INC759.09K589.83K+348.48%5.87M
HHLR ADVISORS, LTD.724.80K00.00%5.60M
AMERIPRISE FINANCIAL INC581.22K581.22KNew4.49M
VESTAL POINT CAPITAL, LP535.45K535.45KNew4.14M
NORTHERN TRUST CORP468.38K412.87K+743.77%3.62M
BOOTHBAY FUND MANAGEMENT, LLC464.10K464.10KNew3.59M
ADAR1 CAPITAL MANAGEMENT, LLC437.50K437.50KNew3.38M
FARALLON CAPITAL MANAGEMENT, L.L.C.415.00K415.00KNew3.21M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Sagimet Biosciences (SGMT) Stock Insights

SGMT$10.53+0.10 +1.01%

$342.92M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History